Fingerprint
Dive into the research topics of 'A phase II study of bevacizumab and erlotinib after radiation and temozolomide in MGMT unmethylated GBM patients'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase II study of bevacizumab and erlotinib after radiation and temozolomide in MGMT unmethylated GBM patients
J. J. Raizer, P. Giglio, J. Hu, M. Groves, R. Merrell, C. Conrad, S. Phuphanich, V. K. Puduvalli, M. Loghin, N. Paleologos, Y. Yuan, D. Liu, A. Rademaker, W. K. Yung, B. Vaillant, J. Rudnick, M. Chamberlain, N. Vick, S. Grimm, I. W. Tremont-Lukats
Research output: Contribution to journal › Article › peer-review
51
Scopus
citations